$18.35
1.01%
Downside
Day's Volatility :1.3%
Upside
0.3%
30.08%
Downside
52 Weeks Volatility :35.95%
Upside
8.39%
Period | Sabra Health Care Reit Inc | Sector (Real Estate) | Index (Russel 2000) |
---|---|---|---|
3 Months | 13.38% | 2.8% | 0.0% |
6 Months | 27.8% | 12.9% | 0.0% |
1 Year | 27.09% | 20.5% | 0.0% |
3 Years | 29.42% | -9.8% | -24.5% |
Market Capitalization | 4.3B |
Book Value | $11.60 |
Dividend Share | 1.2 |
Dividend Yield | 6.58% |
Earnings Per Share (EPS) | 0.41 |
PE Ratio | 44.34 |
PEG Ratio | 3.15 |
Wall Street Target Price | 19.591 |
Profit Margin | 14.22% |
Operating Margin TTM | 36.32% |
Return On Assets TTM | 2.83% |
Return On Equity TTM | 3.46% |
Revenue TTM | 683.2M |
Revenue Per Share TTM | 2.94 |
Quarterly Revenue Growth YOY | 10.7% |
Gross Profit TTM | 372.8M |
EBITDA | 407.4M |
Diluted Eps TTM | 0.41 |
Quarterly Earnings Growth YOY | 0.11 |
EPS Estimate Current Year | 0.51 |
EPS Estimate Next Year | 0.67 |
EPS Estimate Current Quarter | 0.16 |
EPS Estimate Next Quarter | 0.16 |
What analysts predicted
Upside of 6.76%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 623.4M | ↑ 53.68% |
Net Income | 279.1M | ↑ 76.21% |
Net Profit Margin | 44.77% | ↑ 5.73% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 661.7M | ↑ 6.15% |
Net Income | 69.0M | ↓ 75.28% |
Net Profit Margin | 10.43% | ↓ 34.34% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 598.6M | ↓ 9.55% |
Net Income | 138.4M | ↑ 100.62% |
Net Profit Margin | 23.12% | ↑ 12.69% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 569.5M | ↓ 4.85% |
Net Income | -113.3M | ↓ 181.82% |
Net Profit Margin | -19.89% | ↓ 43.01% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 624.8M | ↑ 9.7% |
Net Income | -77.6M | ↓ 31.48% |
Net Profit Margin | -12.42% | ↑ 7.47% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 655.8M | ↑ 4.97% |
Net Income | 13.8M | ↓ 117.73% |
Net Profit Margin | 2.1% | ↑ 14.52% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 161.2M | ↓ 0.1% |
Net Income | 21.2M | ↓ 323.34% |
Net Profit Margin | 13.15% | ↑ 19.03% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 161.6M | ↑ 0.29% |
Net Income | -15.1M | ↓ 171.27% |
Net Profit Margin | -9.34% | ↓ 22.49% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 164.4M | ↑ 1.7% |
Net Income | 17.2M | ↓ 213.61% |
Net Profit Margin | 10.44% | ↑ 19.78% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 172.2M | ↑ 4.75% |
Net Income | 26.3M | ↑ 53.03% |
Net Profit Margin | 15.25% | ↑ 4.81% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 178.5M | ↑ 3.68% |
Net Income | 24.0M | ↓ 8.68% |
Net Profit Margin | 13.43% | ↓ 1.82% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 94.6M | ↓ 47.04% |
Net Income | 29.8M | ↑ 24.25% |
Net Profit Margin | 31.5% | ↑ 18.07% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 6.7B | ↓ 5.22% |
Total Liabilities | 3.4B | ↓ 5.13% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 6.1B | ↓ 8.94% |
Total Liabilities | 2.6B | ↓ 24.33% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 6.0B | ↓ 1.38% |
Total Liabilities | 2.6B | ↓ 0.17% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 6.0B | ↓ 0.32% |
Total Liabilities | 2.6B | ↑ 0.42% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 5.7B | ↓ 3.67% |
Total Liabilities | 2.7B | ↑ 4.02% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 5.4B | ↓ 6.29% |
Total Liabilities | 2.6B | ↓ 4.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.5B | ↓ 0.58% |
Total Liabilities | 2.6B | ↑ 0.02% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↓ 2.6% |
Total Liabilities | 2.5B | ↓ 2.67% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↑ 0.1% |
Total Liabilities | 2.6B | ↑ 2.86% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↓ 0.22% |
Total Liabilities | 2.6B | ↑ 0.92% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↓ 0.43% |
Total Liabilities | 2.6B | ↓ 0.7% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 5.4B | ↑ 0.28% |
Total Liabilities | 2.6B | ↑ 1.24% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 358.5M | ↑ 168.6% |
Investing Cash Flow | -258.5M | ↑ 7.67% |
Financing Cash Flow | -629.3M | ↓ 205.1% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 372.5M | ↑ 3.89% |
Investing Cash Flow | 262.8M | ↓ 201.68% |
Financing Cash Flow | -646.2M | ↑ 2.68% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 354.9M | ↓ 4.73% |
Investing Cash Flow | -136.5M | ↓ 151.91% |
Financing Cash Flow | -202.1M | ↓ 68.72% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 356.4M | ↑ 0.43% |
Investing Cash Flow | -336.2M | ↑ 146.39% |
Financing Cash Flow | 30.1M | ↓ 114.91% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 315.7M | ↓ 11.41% |
Investing Cash Flow | -216.2M | ↓ 35.68% |
Financing Cash Flow | -161.7M | ↓ 636.52% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 70.3M | ↑ 2.99% |
Investing Cash Flow | -8.2M | ↓ 107.24% |
Financing Cash Flow | -68.5M | ↓ 65.08% |
Sell
Neutral
Buy
Sabra Health Care Reit Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Sabra Health Care Reit Inc | -1.08% | 27.8% | 27.09% | 29.42% | -14.98% |
Healthpeak Properties, Inc. | -3.38% | 8.51% | 92.2% | 17.81% | 16.4% |
Ventas, Inc. | -0.87% | 32.54% | 44.0% | 27.43% | 11.52% |
Welltower Inc. | 5.64% | 35.91% | 54.83% | 63.55% | 64.55% |
Omega Healthcare Investors Inc. | -3.48% | 25.73% | 25.17% | 37.52% | -2.73% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Sabra Health Care Reit Inc | 44.34 | 44.34 | 3.15 | 0.51 | 0.03 | 0.03 | 0.07 | 11.6 |
Healthpeak Properties, Inc. | 42.57 | 43.67 | 4.08 | 0.15 | 0.04 | 0.02 | 0.06 | 12.24 |
Ventas, Inc. | 2223.5 | NA | 2.28 | 0.0 | -0.01 | 0.02 | 0.03 | 23.28 |
Welltower Inc. | 87.83 | 87.46 | 2.34 | 1.46 | 0.03 | 0.02 | 0.02 | 49.05 |
Omega Healthcare Investors Inc. | 29.49 | 29.52 | 1.13 | 1.15 | 0.09 | 0.04 | 0.07 | 15.69 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Sabra Health Care Reit Inc | Buy | $4.3B | -14.98% | 44.34 | 14.22% |
Healthpeak Properties, Inc. | Buy | $14.6B | 16.4% | 42.57 | 12.11% |
Ventas, Inc. | Buy | $27.0B | 11.52% | 2223.5 | -1.39% |
Welltower Inc. | Buy | $85.3B | 64.55% | 87.83 | 12.12% |
Omega Healthcare Investors Inc. | Hold | $11.1B | -2.73% | 29.49 | 34.41% |
Insights on Sabra Health Care Reit Inc
Revenue is down for the last 2 quarters, 178.53M → 94.55M (in $), with an average decrease of 47.0% per quarter
Netprofit is up for the last 2 quarters, 23.97M → 29.78M (in $), with an average increase of 19.5% per quarter
In the last 1 year, Healthpeak Properties, Inc. has given 92.2% return, outperforming this stock by 65.1%
Vanguard Group Inc
BlackRock Inc
Principal Financial Group Inc
State Street Corp
Geode Capital Management, LLC
HHG PLC
In the quarter ending March,2024. Sabra Health Care Reit Inc has declared dividend of $0.30
Read Moresabra health care reit, inc. is a self-administered, self-managed realty company that owns and invests in real estate serving the healthcare industry. sabra, a maryland corporation, generates revenues by leasing properties to local, regional and national tenants and operators throughout the united states.
Organization | Sabra Health Care Reit Inc |
Employees | 48 |
CEO | Mr. Richard K. Matros |
Industry | Finance |
Xp Inc.
$18.35
-0.22%
Evolent Health, Inc. - Class A Shares
$18.35
-0.22%
Cullen/frost Bankers, Inc.
$18.35
-0.22%
Dimensional Us Core Equity M
$18.35
-0.22%
Silicon Laboratories Inc
$18.35
-0.22%
Sensient Technologies Corp
$18.35
-0.22%
Option Care Health Inc
$18.35
-0.22%
Summit Materials, Inc.
$18.35
-0.22%
American States Water Co
$18.35
-0.22%